3. Normal eye changes in pregnancy
Pregnancy induced chorioretinopathy
Retinal diseases that are affected by pregnancy
4.
Cornea
◦ increase thickness 1
◦ Increase curvature 2
◦ Decrease sensitivity 3
Lens
◦ Increase thickness 1
◦ Increase curvature 1
IOP
◦ Decrease in 3rd trimester 4
1 Riss B, Riss P. Corneal sensitivity in pregnancy. Ophthalmologica 1981; 183:57—62.
2 Weinreb RN, Lu A, Beeson C. Maternal corneal thickness during pregnancy. Am J Ophthalmol 1988; 105:258—260.
3 Park SB, Lindahl KJ, Temnycky GO, Aquavella JV. The effect of pregnancy on the corneal curvature. CLAO J 1992; 18:256—259.
4 Akar Y, Yucel I, Akar ME, et al. Effect of pregnancy on intraobserver and intertechnique agreement in intraocular pressure measurements.
Ophthalmologica 2005; 219:36—42.
5.
Retina
◦ Retinal thickness
slightly increases during 2nd-3rd
trimesters 1
◦ Retinal venous diameter
decreased during the 3rd trimester 2
1. Dinn, Robert B. BS*; Harris, Alon MSc, PhD†; Marcus, Peter S. MD‡. Ocular Changes in Pregnancy. Obstetrical &
Gynecological Survey:
February 2003 - Volume 58 - Issue 2 - pp 137-144
2. The effect of pregnancy on retinal hemodynamics in diabetic versus nondiabetic mothers ☆
Lisa S Schocket, MDa, Juan E Grunwald, MDa, , , Amy F Tsang, MAa, Joan DuPonta American Journal of OphthalmologyVolume
128, Issue 4, October 1999, Pages 477–484
6. ●
●
Early preg -> hyperdynamic circulation
controlled by an autoregulatory mechanism in the
retinal vasculature
Success
not develop retinopathy
–
–
Failed
increased blood flow velocity
petential damage to capillary endothelium
Chen HC et al. Retinal blood flow changes during pregnancy in women with diabetes. Invest Ophthalmol Vis Sci 1994;
35:3199–3208.
9. ●
●
10:1 male predominance outside the context of
pregnancy
closure when women become pregnant
Chumbley LC, Frank RN. Central serous retinopathy and pregnancy. Am J Ophthalmol 1974; 77:158—160.
10. ●
CSCR
●
●
●
unilateral
with or without fibrin formation
Most cases
●
●
occurred during the 3rd trimester
recurring in subsequent pregnancies
Sunness JS, Haller JA, Fine SL. Central serous chorioretinopathy and pregnancy. Arch Ophthalmol 1993; 111:360—364.
Gass JDM. Central serous chorioretinopathy and white subretinal exudation during pregnancy. Arch Ophthalmol 1991; 109:677—681.
12. ●
●
●
unilateral or bilateral
self limiting
increased intra-thoracic or
intraabdominal pressure
●
●
●
sharp rise in the intraocular venous pressure
rupture of superficial
retinal capillaries
Constipation/ delivery
13. ●
No specific treatment is needed
●
●
Laser posterior hyaloidotomy
the diagnosis should be made only after excluding
other causes of retinal haemorrhages
14. ●
(reported) developing after child birth
●
●
●
Preeclampsia/ eclampsia
compliment activated leuko-embolus formation?
No treatment is needed
15. ●
How common
●
●
●
●
25% of the patients with preeclampsia
50% with eclampsia
Mostly asymptomatic
Few suffers visual disturbance
●
blurred vision, diplopia, photopsia, scotomata, amaurosis and
chromatopsia and cortical blindness
DieckmannWJ (1952) The toxemias of pregnancy, 2nd edn. Mosby, St Louis
16. ●
common ocular findings
●
●
●
●
●
Focal/ general constriction or
spasm of the retinal arterioles
CWS
intra retinal haemorrhages,
retinal oedema
optic nerve oedema
in a patient with mild
preeclampsia
●
Look for cowexisting DM/
chronic HT
Jaffe G, Schatz H Ocular manifestations of preeclampsia. Am
J Ophthalmol 1987;103:309–315
17. ●
Choroidal involvement
●
●
yellow- white focal lesions at the level of
the RPE
serous retinal detachment
●
●
●
often bullous
usually bilateral
Elschnig’s spots
●
●
small, isolated areas of
hyperpigmentation
surrounding yellow or red halos
A.M. Joussen, T.W.Gardner, B. Kirchhof , S.J. Ryan . Retinal Vascular Disease:691-699
18. ●
prognosis
●
●
●
Good
Generally do not need specific
treatment
But NEED Systemic
treatment
●
●
●
antihypertensive therapy
magnesium sulfate
early delivery of the fetus when
indicated
A.M. Joussen, T.W.Gardner, B. Kirchhof , S.J. Ryan . Retinal Vascular Disease:691-699
21. ●
Changes in hemodynamics
increased level of various growth factors and
hormones
●
DR may start/ progress during pregnancy
●
Who will be attacked? Risk factors
●
22. DM duration
<15 yrs
DR
Progression
18%
> 15 yrs
39%
Chew EY, Mills JL, Metzger BE, et al. Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study.
DiabetesCare 1995; 18:631—637.
23. ●
The Diabetes in Early Pregnancy Study (DIEP)
–
Prospective cohort
–
140 pregnant diabetic women
–
Retinopathy was most likely to progress in
●
Poorest control at baseline
●
largest improvement during early pregnancy
Chew EY, Mills JL, Metzger BE, et al. Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study.
DiabetesCare 1995; 18:631—637.
24. Baseline DR
progression
No DR
10.3%
Progression to
PDR
-
Only
microaneurysms
Mild NPDR
21.1%
-
18.8%
6.3%
Moderate NPDR
54.8%
29%
Chew EY, Mills JL, Metzger BE, et al. Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study.
DiabetesCare 1995; 18:631—637.
25. ●
●
additionally hazardous during pregnancy
In at least one major study,
●
all patients with severe PDR
●
●
also had proteinuria indicating a generalized vasculopathy
DR in patients with eclampsia/preeclampsia is more likely to
progress
Phelps RL et al Changes in diabetic retinopathy during pregnancy. Correlations with regulation of hyperglycemia. Arch Ophthalmol 1984;
104:1806–1810
26. ●
rapid normalization of sugar level
●
●
●
hypoglycemia
retinal hypoxia and
new CWS and intra retinal microvascular
abnormalities
Chew EY, Mills JL, Metzger BE, et al. Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study.
DiabetesCare 1995; 18:631—637.
27. Risk factors for the DR progression
●
–
Duration of DM 1
Poor metabolic control
–
Baseline severity of DR
–
HT, PIH and preeclampsia 2,3
–
Rapid normalization of glucose levels during pregnancy 1
–
1.
2.
●
1. Chew EY, Mills JL, Metzger BE, et al. Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy
Study. DiabetesCare 1995; 18:631—637.
2. Rosenn B, Miodovnik M, Kranias G, et al. Progression of diabetic retinopathy in pregnancy: association with hypertension in
pregnancy. Am J Obstet Gynecol 1992; 166:1214—1218.
8. Loukovaara S, Harju M, Kaaja R, Immonen I. Retinal capillary blood flow in diabetic and nondiabetic women during
pregnancy and postpartum period. Invest Ophthalmol Vis Sci 2003; 44:1486—1491.
28. I know it
●
●
●
early education and good
counselling of diabetic
women in childbearing age
good glucose control
Treat diabetic retinopathy
prior to conception
29. ●
●
DR that progress during pregnancy commonly
regress after delivery
But somes with rapid progression or high-risk PDR
will progress
●
Can cause VH/ TRD/ NVG/ blindness
●
Should be treated
Chan WC, Lim LT, Quinn MJ, et al. Management and outcome of sightthreatening diabetic retinopathy in pregnancy. Eye 2004; 18:826—
832.
30.
31. ●
non-infectious uveitis
●
●
●
May flare-up in disease activity within the 1st trimester
And then slow down later
Rebound within 6 months of delivery.
Peter K Rabiah,Albert T Vitale. Noninfectious uveitis and pregnancy. American Journal of Ophthalmology 2003; 136:91-98
32. ●
Most common
●
●
VKH and Behcet disease
Most flare-ups were
effectively treated with
observation/corticosteroids
Peter K Rabiah,Albert T Vitale. Noninfectious uveitis and pregnancy. American Journal of Ophthalmology 2003; 136:91-98